Recro Pharma REPH

$ 1.4 -4.76%

Annual report 2023
added 03-22-2024

Recro Pharma Cash and Cash Equivalents 2011-2024 | REPH

Annual Cash and Cash Equivalents Recro Pharma

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
8.1 M	15 M	25.2 M	23.8 M	19.1 M	38.5 M	61 M	64.5 M	19.8 M	19.7 M	12.8 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.5 M	12.8 K	26.8 M

Quarterly Cash and Cash Equivalents Recro Pharma

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.16 M	4.7 M	6.29 M	15 M	11.6 M	15.5 M	15.3 M	25.2 M	23.5 M	45.7 M	11.6 M	23.8 M	23.8 M	23.8 M	23.8 M	19.1 M	19.1 M	19.1 M	19.1 M	38.5 M	38.5 M	38.5 M	38.5 M	61 M	61 M	61 M	61 M	64.5 M	64.5 M	64.5 M	64.5 M	19.8 M	19.8 M	19.8 M	19.8 M	19.7 M	19.7 M	19.7 M	19.7 M	13 K	12.8 K	12.8 K	12.8 K	53.3 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
64.5 M	12.8 K	26.5 M